Cognitive enhancers in the treatment of substance use disorders: Clinical evidence

Pharmacology Biochemistry and Behavior

Volumn 99, Issue 2, 2011, Pages 285-294

  Brady, Kathleen T ^a,b   Gray, Kevin M ^a   Tolliver, Bryan K ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Addiction; Cognition; Learning and memory; Medications; Pharmacotherapy; Substance use disorders

Indexed keywords

ACETYLCHOLINE; ACETYLCYSTEINE; ALCOHOL; ARIPIPRAZOLE; ATOMOXETINE; COCAINE; CYCLOSERINE; DEXAMPHETAMINE; DONEPEZIL; DOPAMINE; GALANTAMINE; GLUTAMIC ACID; GUANFACINE; MEMANTINE; METHAMPHETAMINE; METHYLPHENIDATE; MINOCYCLINE; MODAFINIL; NICOTINE; NOOTROPIC AGENT; PLACEBO; RIVASTIGMINE; TIAGABINE; VARENICLINE;

ALCOHOLISM; ATTENTION; ATTENTION DEFICIT DISORDER; CANNABIS ADDICTION; CHILDHOOD DISEASE; COCAINE DEPENDENCE; COGNITIVE THERAPY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TARGETING; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; EXECUTIVE FUNCTION; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; NARCOLEPSY; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT DURATION; TREATMENT OUTCOME;

ADRENERGIC AGENTS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOLINESTERASE INHIBITORS; COGNITION; EXCITATORY AMINO ACID AGENTS; HUMANS; NEUROTRANSMITTER AGENTS; NICOTINIC AGONISTS; NOOTROPIC AGENTS; SUBSTANCE-RELATED DISORDERS;

EID: 79958276421     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.04.017     Document Type: Review

References (140)

1. B. Adinoff, M.D. Devous Sr.; M.J. Williams, S.E. Best, T.S. Harris, and A. Minhajuddin Altered neural cholinergic receptor systems in cocaine-addicted subjects Neuropsychopharmacology 35 2010 1485 1499
2. J.C. Adkins, and S. Noble Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy Drugs 55 1998 437 460 (Pubitemid 28112251)
3. E. Aharonovich, A.C. Brooks, E.V. Nunes, and D.S. Hasin Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome Drug Alcohol Depend 95 2008 279 283
4. E. Aharonovich, D.S. Hasin, A.C. Brooks, X. Liu, A. Bisaga, and E.V. Nunes Cognitive deficits predict low treatment retention in cocaine dependent patients Drug Alcohol Depend 81 2006 313 322 (Pubitemid 43152458)
5. A.L. Anderson, M.S. Reid, S.H. Li, T. Holmes, L. Shemanski, and A. Slee Modafinil for the treatment of cocaine dependence Drug Alcohol Depend 104 2009 133 139
6. E.G. Antzoulatos, and J.H. Byrne Learning insights transmitted by glutamate Trends Neurosci 27 2004 555 560 (Pubitemid 39149825)
7. A. Arnsten Stimulants: Therapeutic actions in ADHD Neuropsychopharmacology 31 2007 2376 2383 (Pubitemid 44607054)
8. G. Aston-Jones, and J.D. Cohen Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance J Comp Neurol 493 2005 99 110 (Pubitemid 41637975)
9. G. Atzori, C.A. Lemmonds, M.L. Kotler, M.J. Durcan, and J. Boyle Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal J Clin Psychopharmacol 28 2008 667 674
10. J.E. Bailey, A. Papadopoulos, A. Lingford-Hughes, and D.J. Nutt D-Cycloserine and performance under different states of anxiety in healthy volunteers Psychopharmacology (Berl) 193 2007 579 585 (Pubitemid 47094382)
11. D.J. Balfour, and K.O. Fagerstrom Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders Pharmacol Ther 72 1996 51 81 (Pubitemid 26375476)
12. J.S. Ballon, and D. Feifel A systematic review of modafinil: Potential clinical uses and mechanisms of action J Clin Psychiatry 67 2006 554 566 (Pubitemid 43764232)
13. C.W. Berridge, and B.D. Waterhouse The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes Brain Res Brain Res Rev 42 2003 33 84 (Pubitemid 36369264)
14. W.K. Bickel, R. Yi, R.D. Landes, P.F. Hill, and C. Baxter Remember the future: working memory training decreases delay discounting among stimulant addicts Biol Psychiatry 69 2011 260 265
15. A. Bisaga, and S.M. Evans Acute effects of memantine in combination with alcohol in moderate drinkers Psychopharmacology (Berl) 172 2004 16 24 (Pubitemid 38299746)
16. A.R. Brennan, and A.F. Arnsten Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function Ann N Y Acad Sci 1129 2008 236 245 (Pubitemid 351990277)
17. F.P. Bymaster, J.S. Katner, D.L. Nelson, S.K. Hemrick-Luecke, P.G. Threlkeld, and J.H. Heiligenstein Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology 27 2002 699 711 (Pubitemid 35335888)
18. K.M. Carroll, B.D. Kiluk, C. Nich, T.A. Babuscio, J.A. Brewer, and M.N. Potenza Cognitive function and treatment response in a randomized clinical trial of computer-based training in cognitive-behavioral therapy Subst Use Misuse 46 2011 23 34
19. X. Castells, M. Casas, X. Vidal, R. Bosch, C. Roncero, and J.A. Ramos-Quiroga Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials Addiction 102 2007 1871 1887
20. S.R. Chamberlain, U. Muller, A.D. Blackwell, L. Clark, T.W. Robbins, and B.J. Sahakian Neurochemical modulation of response inhibition and probabilistic learning in humans Science 311 2006 861 863 (Pubitemid 43228852)
21. S.D. Comer, and M.A. Sullivan Memantine produces modest reductions in heroin-induced subjective responses in human research volunteers Psychopharmacology (Berl) 193 2007 235 245 (Pubitemid 47025023)
22. M. Corbetta, G. Patel, and G.L. Shulman The reorienting system of the human brain: from environment to theory of mind Neuron 58 2008 306 324 (Pubitemid 351615192)
23. M.S. Cousins, D.C. Roberts, and H. de Wit GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings Drug Alcohol Depend 65 2002 209 220 (Pubitemid 34159068)
24. D.C. D'Souza, D.S. Charney, and J.H. Krystal Glycine site agonists of the NMDA receptor: A review CNS Drug Reviews 1995
25. C.A. Dackis, K.M. Kampman, K.G. Lynch, H.M. Pettinati, and C.P. O'Brien A double-blind, placebo-controlled trial of modafinil for cocaine dependence Neuropsychopharmacology 30 2005 205 211 (Pubitemid 40024415)
26. C.A. Dackis, K.G. Lynch, E. Yu, F.F. Samaha, K.M. Kampman, and J.W. Cornish Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study Drug Alcohol Depend 70 2003 29 37 (Pubitemid 36385151)
27. M. Davis, and K.M. Myers The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy Biol Psychiatry 52 2002 998 1007 (Pubitemid 35356357)
28. R. De La Garza, J.J. Mahoney III, C. Culbertson, S. Shoptaw, and T.F. Newton The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers Pharmacol Biochem Behav 89 2008 200 208
29. R. De La Garza, T. Zorick, E.D. London, and T.F. Newton Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers Drug Alcohol Depend 106 2010 173 180
30. A. Diehl, H. Nakovics, B. Croissant, M.N. Smolka, A. Batra, and K. Mann Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial Int J Clin Pharmacol Ther 44 2006 614 622 (Pubitemid 44896139)
31. A. Diehl, H. Nakovics, J. Mutschler, D. Hermann, and F. Kiefer Rivastigmine reduces tobacco craving in alcohol-dependent smokers Pharmacopsychiatry 42 2009 89 94
32. J.L. Donovan, C.L. DeVane, R.J. Malcolm, J. Mojsiak, C.N. Chiang, and A. Elkashef Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers Clin Pharmacokinet 44 2005 753 765 (Pubitemid 40994083)
33. Y. Du, Z. Ma, S. Lin, R.C. Dodel, F. Gao, and K.R. Bales Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease Proc Natl Acad Sci USA 98 2001 14669 14674 (Pubitemid 33121449)
34. S.M. Evans, F.R. Levin, D.J. Brooks, and F. Garawi A pilot double-blind treatment trial of memantine for alcohol dependence Alcohol Clin Exp Res 31 2007 775 782 (Pubitemid 46587657)
35. B.J. Everitt, and T.W. Robbins Neural systems of reinforcement for drug addiction: from actions to habits to compulsion Nat Neurosci 8 2005 1481 1489 (Pubitemid 41573659)
36. M. Farlow A clinical overview of cholinesterase inhibitors in Alzheimer's disease Int Psychogeriatr 14 Suppl 1 2002 93 126 (Pubitemid 36206093)
37. M. Field, and W.M. Cox Attentional bias in addictive behaviors: a review of its development, causes, and consequences Drug Alcohol Depend 97 2008 1 20
38. A.E. Fleckenstein, J.W. Gibb, and G.R. Hanson Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity Eur J Pharmacol 406 2000 1 13
39. H.C. Fox, E.D. Jackson, and R. Sinha Elevated cortisol and learning and memory deficits in cocaine dependent individuals: relationship to relapse outcomes Psychoneuroendocrinology 34 2009 1198 1207
40. J.I. Friedman, D.N. Adler, H.D. Temporini, E. Kemether, P.D. Harvey, and L. White Guanfacine treatment of cognitive impairment in schizophrenia Neuropsychopharmacology 25 2001 402 409 (Pubitemid 32777790)
41. Y. Fujita, T. Ishima, S. Kunitachi, H. Hagiwara, L. Zhang, and M. Iyo Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline Prog Neuropsychopharmacol Biol Psychiatry 32 2008 336 339 (Pubitemid 351178944)
42. H. Garavan, J. Pankiewicz, A. Bloom, J.K. Cho, L. Sperry, and T.J. Ross Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli Am J Psychiatry 157 2000 1789 1798
43. J.T. Gass, and M.F. Olive Glutamatergic substrates of drug addiction and alcoholism Biochem Pharmacol 75 2008 218 265 (Pubitemid 350235390)
44. J.M. Glass, A. Buu, K.M. Adams, J.T. Nigg, L.I. Puttler, and J.M. Jester Effects of alcoholism severity and smoking on executive neurocognitive function Addiction 104 2009 38 48
45. P.S. Goldman-Rakic Architecture of the prefrontal cortex and the central executive Ann N Y Acad Sci 769 1995 71 83 (Pubitemid 26075885)
46. K. Grasing, D. Mathur, T.F. Newton, and C. DeSouza Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals Drug Alcohol Depend 107 2010 69 75
47. K.M. Gray, N.L. Watson, M.J. Carpenter, and S.D. Larowe N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study Am J Addict 19 2010 187 189
48. C.L. Hart, M. Haney, S.K. Vosburg, S.D. Comer, E. Gunderson, and R.W. Foltin Modafinil attenuates disruptions in cognitive performance during simulated night-shift work Neuropsychopharmacology 31 2006 1526 1536
49. C.L. Hart, M. Haney, S.K. Vosburg, S.D. Comer, E. Gunderson, and R.W. Foltin Modafinil attenuates disruptions in cognitive performance during simulated night-shift work Neuropsychopharmacology 31 2006 1526 1536
50. C.L. Hart, M. Haney, S.K. Vosburg, E. Rubin, and R.W. Foltin Smoked cocaine self-administration is decreased by modafinil Neuropsychopharmacology 33 2008 761 768 (Pubitemid 351252706)
51. S.H. Heil, H.W. Holmes, W.K. Bickel, S.T. Higgins, G.J. Badger, and H.F. Laws Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users Drug Alcohol Depend 67 2002 149 156 (Pubitemid 34722402)
52. K.G. Heinzerling, A.N. Swanson, S. Kim, L. Cederblom, A. Moe, and W. Ling Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence Drug Alcohol Depend 109 2010 20 29
53. S.J. Heishman, B.A. Kleykamp, and E.G. Singleton Meta-analysis of the acute effects of nicotine and smoking on human performance Psychopharmacology (Berl) 210 2010 453 469
54. D.V. Herin, C.R. Rush, and J. Grabowski Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies Ann N Y Acad Sci 1187 2010 76 100
55. J.R. Hughes, D.K. Hatsukami, R.W. Pickens, D. Krahn, S. Malin, and A. Luknic Effect of nicotine on the tobacco withdrawal syndrome Psychopharmacology (Berl) 83 1984 82 87 (Pubitemid 14141493)
56. A. Jackson, J. Nesic, C. Groombridge, O. Clowry, J. Rusted, and T. Duka Differential involvement of glutamatergic mechanisms in the cognitive and subjective effects of smoking Neuropsychopharmacology 34 2009 257 265
57. P. Jakala, M. Riekkinen, J. Sirvio, E. Koivisto, K. Kejonen, and M. Vanhanen Guanfacine, but not clonidine, improves planning and working memory performance in humans Neuropsychopharmacology 20 1999 460 470 (Pubitemid 29123873)
58. D.R. Jasinski, D.E. Faries, R.J. Moore, L.M. Schuh, and A.J. Allen Abuse liability assessment of atomoxetine in a drug-abusing population Drug Alcohol Depend 95 2008 140 146
59. C.E. Johanson, and M.W. Fischman The pharmacology of cocaine related to its abuse Pharmacol Rev 41 1989 3 52 (Pubitemid 19247826)
60. D. Jovanovski, S. Erb, and K.K. Zakzanis Neurocognitive deficits in cocaine users: a quantitative review of the evidence J Clin Exp Neuropsychol 27 2005 189 204 (Pubitemid 40389048)
61. A.D. Kalechstein, R. De La Garza II, and T.F. Newton Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment Am J Addict 19 2010 340 344
62. P.W. Kalivas, and C. O'Brien Drug addiction as a pathology of staged neuroplasticity Neuropsychopharmacology 33 2008 166 180 (Pubitemid 350191316)
63. P.W. Kalivas, and N.D. Volkow The neural basis of addiction: a pathology of motivation and choice Am J Psychiatry 162 2005 1403 1413 (Pubitemid 41105554)
64. D.L. Kelly, R.P. McMahon, E. Weiner, D.L. Boggs, D. Dickinson, and R.R. Conley Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia Schizophr Res 103 2008 161 168
65. B.D. Kiluk, C. Nich, T. Babuscio, and K.M. Carroll Quality versus quantity: acquisition of coping skills following computerized cognitive-behavioral therapy for substance use disorders Addiction 105 2010 2120 2127
66. E.M. Krupitsky, O. Neznanova, D. Masalov, A.M. Burakov, T. Didenko, and T. Romanova Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients Am J Psychiatry 164 2007 519 523 (Pubitemid 46513168)
67. R. Kuczenski, and D.S. Segal Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine J Neurochem 68 1997 2032 2037 (Pubitemid 27176139)
68. S.D. LaRowe, P. Mardikian, R. Malcolm, H. Myrick, P. Kalivas, and K. McFarland Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals Am J Addict 15 2006 105 110 (Pubitemid 43207196)
69. S.D. LaRowe, H. Myrick, S. Hedden, P. Mardikian, M. Saladin, and A. McRae Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry 164 2007 1115 1117 (Pubitemid 47121401)
70. F.R. Levin, S.M. Evans, D.J. Brooks, and F. Garawi Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo Drug Alcohol Depend 87 2007 20 29 (Pubitemid 46074379)
71. Y. Levkovitz, S. Mendlovich, S. Riwkes, Y. Braw, H. Levkovitch-Verbin, and G. Gal A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia J Clin Psychiatry 71 2010 138 149
72. E.D. London, S.M. Berman, B. Voytek, S.L. Simon, M.A. Mandelkern, and J. Monterosso Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers Biol Psychiatry 58 2005 770 778 (Pubitemid 41677415)
73. M. Longo, W. Wickes, M. Smout, S. Harrison, S. Cahill, and J.M. White Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence Addiction 105 2010 146 154
74. J. Loughead, R. Ray, E.P. Wileyto, K. Ruparel, P. Sanborn, and S. Siegel Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers Biol Psychiatry 67 2010 715 721
75. B.K. Madras, Z. Xie, Z. Lin, A. Jassen, H. Panas, and L. Lynch Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro J Pharmacol Exp Ther 319 2006 561 569
76. R. Malcolm, K. Swayngim, J.L. Donovan, C.L. DeVane, A. Elkashef, and N. Chiang Modafinil and cocaine interactions Am J Drug Alcohol Abuse 32 2006 577 587 (Pubitemid 44870996)
77. K. Mann, K. Ackermann, A. Diehl, D. Ebert, G. Mundle, and H. Nakovics Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trial Psychopharmacology (Berl) 184 2006 115 121 (Pubitemid 43005764)
78. A. McCaddon, and P.R. Hudson L-methylfolate, methylcobalamin, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline CNS Spectr 15 2010 2 5 discussion 6.
79. K. McFarland, C.C. Lapish, and P.W. Kalivas Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior J Neurosci 23 2003 3531 3537 (Pubitemid 36531996)
80. S.A. McKee, E.L. Harrison, S.S. O'Malley, S. Krishnan-Sarin, J. Shi, and J.M. Tetrault Varenicline reduces alcohol self-administration in heavy-drinking smokers Biol Psychiatry 66 2009 185 190
81. D. Michelson, L. Adler, T. Spencer, F.W. Reimherr, S.A. West, and A.J. Allen Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies Biol Psychiatry 53 2003 112 120 (Pubitemid 36126473)
82. D. Michelson, A.J. Allen, J. Busner, C. Casat, D. Dunn, and C. Kratochvil Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study Am J Psychiatry 159 2002 1896 1901 (Pubitemid 35283256)
83. M.J. Minzenberg, and C.S. Carter Modafinil: a review of neurochemical actions and effects on cognition Neuropsychopharmacology 33 2008 1477 1502 (Pubitemid 351684703)
84. M.J. Minzenberg, A.J. Watrous, J.H. Yoon, S. Ursu, and C.S. Carter Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI Science 322 2008 1700 1702
85. M.E. Mooney, D.V. Herin, J.M. Schmitz, N. Moukaddam, C.E. Green, and J. Grabowski Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial Drug Alcohol Depend 101 2009 34 41
86. P.I. Moreira, P.L. Harris, X. Zhu, M.S. Santos, C.R. Oliveira, and M.A. Smith Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts J Alzheimers Dis 12 2007 195 206 (Pubitemid 47509369)
87. P.T. Morgan, E. Pace-Schott, B. Pittman, R. Stickgold, and R.T. Malison Normalizing effects of modafinil on sleep in chronic cocaine users Am J Psychiatry 167 2010 331 340
88. K.M. Myers, W.A. Carlezon Jr.; and M. Davis Glutamate receptors in extinction and extinction-based therapies for psychiatric illness Neuropsychopharmacology 36 2011 274 293
89. M.M. Norberg, J.H. Krystal, and D.F. Tolin A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy Biol Psychiatry 63 2008 1118 1126
90. C.P. O'Brien, G.F. Koob, D. Mee-Lee, and R.N. Rosenthal New developments in addiction treatment J Clin Psychiatry 67 2006 1801 1812 (Pubitemid 44955163)
91. G. Paolone, F. Botreau, and J. Stewart The facilitative effects of D-cycloserine on extinction of a cocaine-induced conditioned place preference can be long lasting and resistant to reinstatement Psychopharmacology (Berl) 202 2009 403 409
92. W.K. Park, A.A. Bari, A.R. Jey, S.M. Anderson, R.D. Spealman, and J.K. Rowlett Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens J Neurosci 22 2002 2916 2925 (Pubitemid 37465840)
93. F. Patterson, C. Jepson, A.A. Strasser, J. Loughead, K.A. Perkins, and R.C. Gur Varenicline improves mood and cognition during smoking abstinence Biol Psychiatry 65 2009 144 149
94. S.R. Pliszka The neuropsychopharmacology of attention-deficit/ hyperactivity disorder Biol Psychiatry 57 2005 1385 1390 (Pubitemid 40798559)
95. L.J. Porrino, H.R. Smith, M.A. Nader, and T.J. Beveridge The effects of cocaine: a shifting target over the course of addiction Prog Neuropsychopharmacol Biol Psychiatry 31 2007 1593 1600 (Pubitemid 47625705)
96. K.L. Price, A.L. McRae-Clark, M.E. Saladin, M.M. Maria, S.M. DeSantis, and S.E. Back D-cycloserine and cocaine cue reactivity: preliminary findings Am J Drug Alcohol Abuse 35 2009 434 438
97. B.P. Ramos, and A.F. Arnsten Adrenergic pharmacology and cognition: focus on the prefrontal cortex Pharmacol Ther 113 2007 523 536 (Pubitemid 46365960)
98. D.C. Randall, J.M. Shneerson, and S.E. File Cognitive effects of modafinil in student volunteers may depend on IQ Pharmacol Biochem Behav 82 2005 133 139 (Pubitemid 41423496)
99. D.C. Randall, A. Viswanath, P. Bharania, S.M. Elsabagh, D.E. Hartley, and J.M. Shneerson Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived? J Clin Psychopharmacol 25 2005 175 179 (Pubitemid 40395097)
100. R. Ray, M. Rukstalis, C. Jepson, A. Strasser, F. Patterson, and K. Lynch Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence J Psychopharmacol 23 2009 168 176
101. D. Repantis, O. Laisney, and I. Heuser Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review Pharmacol Res 61 2010 473 481
102. T.W. Robbins Cortical noradrenaline, attention and arousal Psychol Med 14 1984 13 21 (Pubitemid 14025884)
103. C.R. Rush, T.H. Kelly, L.R. Hays, R.W. Baker, and A.F. Wooten Acute behavioral and physiological effects of modafinil in drug abusers Behav Pharmacol 13 2002 105 115 (Pubitemid 34450696)
104. C.R. Rush, T.H. Kelly, L.R. Hays, and A.F. Wooten Discriminative-stimulus effects of modafinil in cocaine-trained humans Drug Alcohol Depend 67 2002 311 322 (Pubitemid 34786266)
105. R. Salo, T.E. Nordahl, C. Moore, C. Waters, Y. Natsuaki, and G.P. Galloway A dissociation in attentional control: evidence from methamphetamine dependence Biol Psychiatry 57 2005 310 313 (Pubitemid 40187376)
106. E.J. Santa Ana, B.J. Rounsaville, T.L. Frankforter, C. Nich, T. Babuscio, and J. Poling D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation Drug Alcohol Depend 104 2009 220 227
107. S. Sara The locus ceruleus and noradrenergic modulation of cognition Nature Rev Neurosci 10 2009 211 223
108. G.W. Schrimsher, J.D. Parker, and R.S. Burke Relation between cognitive testing performance and pattern of substance use in males at treatment entry Clin Neuropsychol 21 2007 498 510 (Pubitemid 46598789)
109. J.C. Scott, S.P. Woods, G.E. Matt, R.A. Meyer, R.K. Heaton, and J.H. Atkinson Neurocognitive effects of methamphetamine: a critical review and meta-analysis Neuropsychol Rev 17 2007 275 297 (Pubitemid 47498174)
110. J. Shearer, S. Darke, C. Rodgers, T. Slade, I. van Beek, and J. Lewis A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence Addiction 104 2009 224 233
111. J.K. Simosky, K.E. Stevens, and R. Freedman Nicotinic agonists and psychosis Curr Drug Targets CNS Neurol Disord 1 2002 149 162
112. R.C. Smith, J.P. Lindenmayer, J.M. Davis, J. Cornwell, K. Noth, and S. Gupta Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder Schizophr Res 110 2009 149 155
113. F.R. Snyder, F.C. Davis, and J.E. Henningfield The tobacco withdrawal syndrome: performance decrements assessed on a computerized test battery Drug Alcohol Depend 23 1989 259 266 (Pubitemid 19148670)
114. M. Sofuoglu, A.I. Herman, M. Mooney, and A.J. Waters Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans Psychopharmacology (Berl) 207 2009 153 162
115. M. Sofuoglu, M. Mouratidis, S. Yoo, K. Culligan, and T. Kosten Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers Psychopharmacology (Berl) 181 2005 504 510 (Pubitemid 41480899)
116. M. Sofuoglu, and R.A. Sewell Norepinephrine and stimulant addiction Addict Biol 14 2009 119 129
117. M. Sofuoglu Cognitive enhancement as a pharmacotherapy target for stimulant addiction Addiction 2009 10538 10548
118. M. Sofuoglu, D.E. Sugarman, and K.M. Carroll Cognitive function as an emerging treatment target for marijuana addiction Exp Clin Psychopharmacol 18 2010 109 119
119. M. Sofuoglu, A.J. Waters, M. Mooney, and S.S. O'Malley Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans Pharmacol Biochem Behav 92 2009 135 140
120. N. Solowij, and R. Battisti The chronic effects of cannabis on memory in humans: a review Curr Drug Abuse Rev 1 2008 81 98
121. W.W. Stoops, J.W. Blackburn, D.A. Hudson, L.R. Hays, and C.R. Rush Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance Drug Alcohol Depend 92 2008 282 285 (Pubitemid 350213243)
122. D. Swick, V. Ashley, and A.U. Turken Left inferior frontal gyrus is critical for response inhibition BMC Neurosci 9 2008 102
123. F.B. Taylor, and J. Russo Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults J Child Adolesc Psychopharmacol 10 2000 311 320 (Pubitemid 32103907)
124. J. Tiihonen, K. Kuoppasalmi, J. Fohr, P. Tuomola, O. Kuikanmaki, and H. Vorma A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence Am J Psychiatry 164 2007 160 162 (Pubitemid 46154797)
125. D.C. Turner, L. Clark, J. Dowson, T.W. Robbins, and B.J. Sahakian Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder Biol Psychiatry 55 2004 1031 1040 (Pubitemid 38581919)
126. D.C. Turner, T.W. Robbins, L. Clark, A.R. Aron, J. Dowson, and B.J. Sahakian Cognitive enhancing effects of modafinil in healthy volunteers Psychopharmacology (Berl) 165 2003 260 269 (Pubitemid 36197601)
127. W. Vleeming, B. Rambali, and A. Opperhuizen The role of nitric oxide in cigarette smoking and nicotine addiction Nicotine Tob Res 4 2002 341 348 (Pubitemid 34994148)
128. F. Vocci, and W. Ling Medications development: successes and challenges Pharmacol Ther 108 2005 94 108 (Pubitemid 41377122)
129. F.J. Vocci Cognitive remediation in the treatment of stimulant abuse disorders: a research agenda Exp Clin Psychopharmacol 16 2008 484 497
130. N.D. Volkow, J.S. Fowler, J. Logan, D. Alexoff, W. Zhu, and F. Telang Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications Jama 301 2009 1148 1154
131. S.K. Vosburg, C.L. Hart, M. Haney, E. Rubin, and R.W. Foltin Modafinil does not serve as a reinforcer in cocaine abusers Drug Alcohol Depend 106 2010 233 236
132. T.E. Wilens, L.A. Adler, M.D. Weiss, D. Michelson, J.L. Ramsey, and R.J. Moore Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders Drug Alcohol Depend 96 2008 145 154
133. T.M. Winhusen, E.C. Somoza, J.M. Harrer, J.P. Mezinskis, M.A. Montgomery, and R.J. Goldsmith A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments Addiction 100 Suppl 1 2005 68 77 (Pubitemid 40363426)
134. R.A. Wise Catecholamine theories of reward: a critical review Brain Res 152 1978 215 247 (Pubitemid 9003327)
135. R.A. Wise Neurobiology of addiction Curr Opin Neurobiol 6 1996 243 251 (Pubitemid 26168484)
136. R.A. Wise Dopamine, learning and motivation Nat Rev Neurosci 5 2004 483 494 (Pubitemid 38715515)
137. J. Yrjanheikki, T. Tikka, R. Keinanen, G. Goldsteins, P.H. Chan, and J. Koistinaho A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window Proc Natl Acad Sci USA 96 1999 13496 13500
138. L. Zhang, Y. Shirayama, M. Iyo, and K. Hashimoto Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine Neuropsychopharmacology 32 2007 2004 2010 (Pubitemid 47258509)
139. W. Zhou Normalizing drug-induced neuronal plasticity in nucleus accumbens weakens enduring drug-seeking behavior Neuropsychopharmacology 35 2010 352 353
140. T. Zorick, R.J. Sevak, K. Miotto, S. Shoptaw, A.N. Swanson, and C. Clement Pilot Safety Evaluation of Varenicline for the Treatment of Methamphetamine Dependence J Exp Pharmacol 2010 2009 13 18